摘要:
A sealing member for a fuel cell includes a pair of belts that include non-gas transmitting layers formed of aromatic polyimide or aluminum and thermoplastic resin layers. The belts are disposed such that the thermoplastic resin layers of the belts face each other, and the thermoplastic resin layers in outer edge portions of the belts are thermally bonded to each other. In a fuel cell, an inner portion of the belts engage the electrolyte membrane.
摘要:
An image forming apparatus is provided. The image forming apparatus includes a conveyer system, a liquid discharge head with a plurality of nozzles arranged in rows in different positions from one another with reference to a conveying direction at least within a part, a transmitter unit to transmit the image-forming data to the liquid discharge head, a receiver unit to receive the image-forming data, an image-forming data storage unit to store the image-forming data, an error detecting unit to detect a transmission error in the image-forming data, and a controller unit to manipulate the transmitter unit, the liquid discharge head, and the conveying system. The image-forming data with the transmission error detected therein for forming dots in pixel areas in liquid discharged from the nozzles, which are arranged in one of the rows closer to an upstream position with reference to the conveying direction, is transmitted preferentially.
摘要:
Pharmaceutical compositions for enhancing the expression of apoAI are provided, which are used as medicaments for treatment of cardiovascular diseases on the basis of improving the functions of HDL.Pharmaceutical compositions for enhancing the expression of apoAI which comprises a compound of formula (I): in which X1 and X1 are independently an aryl or heteroaryl that may be optionally substituted, a hydrogen, a halogen, or the like; ring A is a benzene ring or 6-membered aromatic heterocyclic ring containing 1 to 3 N atoms that may be optionally condensed with another aromatic ring; R1 to R4 are independently a hydrogen, a halogen, a lower alkyl, a lower alkoxy or the like; a prodrug thereof, a pharmaceutically acceptable salt or solvate of them are disclosed.
摘要翻译:提供了用于增强载脂蛋白A表达的药物组合物,其用于治疗心血管疾病的药物,其基础是改善HDL的功能。 用于增强载脂蛋白A表达的药物组合物,其包含式(I)化合物:其中X1和X1独立地为可任意取代的芳基或杂芳基,氢,卤素等; 环A是含有1〜3个N原子的苯环或6元芳族杂环,其可以任选地与另一个芳环稠合; R 1至R 4独立地为氢,卤素,低级烷基,低级烷氧基等; 公开了其前药,药学上可接受的盐或溶剂合物。
摘要:
The present invention provides a compound of the formula (I): wherein R1, R2, R3 and R4 are each independently hydrogen, optionally substituted alkyl, hydroxy, optionally substituted alkoxy or the like, R5 is optionally substituted alkyl, optionally substituted aryl, optionally substituted heterocyclic or the like, R6 is hydrogen, optionally substituted alkyl or the like, R7 is hydrogen, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted aryl, optionally substituted heterocyclic or the like, A is S or O and a broken line represents presence or absence of a bond, pharmaceutically acceptable salt or hydrate thereof and a pharmaceutical composition or a pharmaceutical composition for use as an endothelin receptor antagonist, a peripheral circulation insufficiency-improving agent or a macrophage foam cell formation inhibitor comprising the compound.